| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:LY 266097 hydrochloride CAS:172895-39-5 Purity:>=99% by HPLC Remarks:Reach out to us for more information about custom solutions.
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:LY 266097 hydrochloride CAS:172895-39-5 Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:LY 266097 hydrochloride CAS:172895-39-5 Purity:>=99%(HPLC) Package:100mg Remarks:S55538
|
LY 266097 hydrochloride manufacturers
|
| | LY 266097 hydrochloride Basic information |
| Product Name: | LY 266097 hydrochloride | | Synonyms: | LY 266097 hydrochloride;LY 266097;LY266097;LY266097 >=98% (HPLC), powder;LY-266097 hydrochloride,LY266097 hydrochloride;LY266097 hydrochloride, 10 mM in DMSO;1-[(2-Chloro-3,4-dimethoxyphenyl)methyl]-2,3,4,9-tetrahydro-6-methyl-1H-pyrido[3,4-b]indole hydrochloride | | CAS: | 172895-39-5 | | MF: | C21H24Cl2N2O2 | | MW: | 407.34 | | EINECS: | | | Product Categories: | | | Mol File: | 172895-39-5.mol |  |
| | LY 266097 hydrochloride Chemical Properties |
| storage temp. | 2-8°C | | solubility | DMSO: ≥20mg/mL | | form | powder | | color | white to tan | | InChI | 1S/C21H23ClN2O2.ClH/c1-12-4-6-16-15(10-12)14-8-9-23-17(20(14)24-16)11-13-5-7-18(25-2)21(26-3)19(13)22;/h4-7,10,17,23-24H,8-9,11H2,1-3H3;1H | | InChIKey | KPXKZZURYAXZQE-UHFFFAOYSA-N | | SMILES | Cl.COc1ccc(CC2NCCc3c2[nH]c4ccc(C)cc34)c(Cl)c1OC |
| WGK Germany | 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Eye Irrit. 2 |
| | LY 266097 hydrochloride Usage And Synthesis |
| Uses | LY 266097 Hydrochloride is a potent and selective serotonin 2B (5HT2B) contractile receptor. | | Biological Activity | LY266097 is a selective 5HT-2B antagonist with a pKI of 9.7 for the human cloned 5-HT2B receptor and a 100-fold greater selectivity for 5-HT2B than the human 5-HT2C and 5-HT2A. | | in vivo | LY266097 (0.6 mg/kg for 2-day administration) rescues Escitalopram-induced decrease in dopamine (DA) [1].
The administration of LY266097 alone or its addition on the last 3 days of a 14-day Escitalopram regimen increases pyramidal neuron firing and burst activity[1]. | Animal Model: | Male Sprague-Dawley rats weighing 250-350g[1] | | Dosage: | 0.6mg/kg | | Administration: | Administered i.p. alone or concomitantly with Escitalopram (2mg/kg) for 2 days | | Result: | Short-term administration (0.6mg/kg/day for 2 days; i.p.) alone had no effect on these parameters, its co-administration counteracted the inhibitory effect of escitalopram on the firing activity of DA neurons, resulting in a recovery to control level. |
| | IC 50 | 5-HT2B Receptor: 9.8 (pKi); 5-HT2A Receptor: 7.7 (pKi); 5-HT2C Receptor: 7.6 (pKi) | | storage | Store at +4°C |
| | LY 266097 hydrochloride Preparation Products And Raw materials |
|